10d
Stockhead on MSNRare opportunities – ASX health stocks tackling unmet medical needsRare diseases have become an attractive target for pharmaceutical companies both on the ASX and internationally.
A recent study said that adults with chronic back pain should not be given spine injections as they provide little or no pain relief when compared to sham injections. The study was published on ...
Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD in postmenopausal women with T2D.
The new rule goes into effect Feb. 25, 2025, with a compliance date in 2028. A new label on the front of food packages is being proposed to help consumers easily see saturated fat, sodium and ...
This study demonstrates the critical role of Afadin on the generation and maintenance of complex cellular layers in the mouse retina. The data are solid, which provides important insights into how ...
Researchers at Jilin University (Changchun, China) developed a highly sensitive, rapid, and accurate method for analyzing ...
A new study indicates that the ... Feb. 5, 2025 — Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA ...
They had a -3 point differential that year, so it wasn't surprising when they were labeled a regression candidate and ultimately did regress in a big way, going 7-10 in 2023 (though injuries to ...
Would a Birkin handbag be less appealing if it was made in Paris, Texas, rather than the French capital? Most luxury brands have clung tightly to their European manufacturing base, but a move ...
Stryker has agreed to sell its U.S. spinal implants business to Viscogliosi Brothers to create a newly formed company called VB Spine. The medical technology company said Tuesday the New York City ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results